Min Lv

1.3k total citations
57 papers, 897 citations indexed

About

Min Lv is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Min Lv has authored 57 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 14 papers in Infectious Diseases and 10 papers in Health. Recurrent topics in Min Lv's work include Influenza Virus Research Studies (20 papers), Vaccine Coverage and Hesitancy (10 papers) and Respiratory viral infections research (10 papers). Min Lv is often cited by papers focused on Influenza Virus Research Studies (20 papers), Vaccine Coverage and Hesitancy (10 papers) and Respiratory viral infections research (10 papers). Min Lv collaborates with scholars based in China, United States and Australia. Min Lv's co-authors include Jiang Wu, Shuang Bai, Pei Gao, Qianli Yuan, Weixin Chen, Jianzhong Zhang, Fei Zhao, Xiaoxia Tao, Yufeng Xiao and Zheng Xie and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Min Lv

55 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Lv China 14 648 169 166 129 122 57 897
Changtai Zhu China 18 269 0.4× 85 0.5× 53 0.3× 277 2.1× 45 0.4× 54 807
Denise Pui Chung Chan Hong Kong 19 651 1.0× 162 1.0× 64 0.4× 453 3.5× 31 0.3× 56 1.2k
Erin Burns United States 15 947 1.5× 35 0.2× 18 0.1× 243 1.9× 200 1.6× 26 1.4k
Eun Hee Chung South Korea 13 340 0.5× 29 0.2× 126 0.8× 154 1.2× 16 0.1× 61 702
Florencia Wendkuuni Djigma Burkina Faso 18 559 0.9× 196 1.2× 84 0.5× 168 1.3× 10 0.1× 118 976
Hui Zheng China 18 760 1.2× 703 4.2× 7 0.0× 199 1.5× 142 1.2× 61 1.1k
Xuewen Tang China 11 201 0.3× 60 0.4× 27 0.2× 99 0.8× 186 1.5× 26 450
Benjamin Wyplosz France 15 185 0.3× 34 0.2× 86 0.5× 115 0.9× 27 0.2× 60 608
Verónica Saludes Spain 15 338 0.5× 334 2.0× 47 0.3× 105 0.8× 9 0.1× 38 527
Pei Gao China 14 509 0.8× 185 1.1× 9 0.1× 125 1.0× 24 0.2× 37 695

Countries citing papers authored by Min Lv

Since Specialization
Citations

This map shows the geographic impact of Min Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Lv more than expected).

Fields of papers citing papers by Min Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Lv. The network helps show where Min Lv may publish in the future.

Co-authorship network of co-authors of Min Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Min Lv. A scholar is included among the top collaborators of Min Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Lv. Min Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Manyu, Meng‐yuan Zhou, Yujie Zhou, et al.. (2025). Acetazolamide as an aquaporin 1 inhibitor mitigates rheumatoid arthritis by reducing angiogenesis via the modulation of the FAK-PI3K/Akt signaling pathway. International Immunopharmacology. 158. 114845–114845.
2.
Ma, Yuan, Feng Lu, Luodan Suo, et al.. (2024). Effectiveness of influenza vaccines in preventing acute cardiovascular events within 1 year in Beijing, China. npj Vaccines. 9(1). 177–177. 3 indexed citations
3.
Liu, Guangqi, Yuanjie Pang, Min Lv, et al.. (2024). Effectiveness of influenza vaccination on hospitalization outcomes among older patients with diabetes. Vaccine. 42(25). 126142–126142. 2 indexed citations
4.
Shen, Yang, Jingyu Wang, Jian Wang, et al.. (2024). Effectiveness of financial incentives on influenza vaccination among older adults in China: a randomized clinical trial. Clinical Microbiology and Infection. 30(7). 911–916. 2 indexed citations
5.
Wang, Jian, Qiu Li, Shuang Bai, et al.. (2024). Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae among healthy children under 5 years of age in Hainan Province, China. Infectious Diseases of Poverty. 13(1). 7–7. 3 indexed citations
6.
7.
Shen, Yang, Jingyu Wang, Min Lv, et al.. (2024). Predicting future vaccination habits: The link between influenza vaccination patterns and future vaccination decisions among old aged adults in China. Journal of Infection and Public Health. 17(6). 1079–1085. 2 indexed citations
8.
Xie, Hui, Shuang Bai, Min Lv, et al.. (2024). The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants. International Journal of Infectious Diseases. 144. 107060–107060. 1 indexed citations
9.
Wang, Ming, Dawei Zhu, Rui Yu, et al.. (2023). Data envelopment analysis on the efficiency of vaccination services and its influencing factors in Beijing, China. BMC Health Services Research. 23(1). 737–737. 2 indexed citations
10.
Bai, Shuang, Weixin Chen, Hui Xie, et al.. (2023). Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice. Viral Immunology. 36(8). 526–533. 1 indexed citations
11.
Zhao, Wei, Weixin Chen, Juan Li, et al.. (2022). Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19. mBio. 13(3). e0018122–e0018122. 24 indexed citations
12.
Pang, Yuanjie, et al.. (2022). Effectiveness of influenza vaccination on in-hospital death in older adults with respiratory diseases. Human Vaccines & Immunotherapeutics. 18(6). 2117967–2117967. 4 indexed citations
13.
14.
Gao, Pei, Weixin Chen, Qianli Yuan, et al.. (2022). A cross-sectional study of alcohol consumption and alcoholic liver disease in Beijing: based on 74,998 community residents. BMC Public Health. 22(1). 723–723. 9 indexed citations
15.
Liu, Jiayi, Yeyu Cai, Ziyi Zhou, et al.. (2021). Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging. Journal of Magnetic Resonance Imaging. 55(6). 1864–1874. 12 indexed citations
16.
Shi, Xuefeng, et al.. (2021). Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing. Human Vaccines & Immunotherapeutics. 17(6). 1818–1824. 12 indexed citations
17.
Zhao, Wei, Peng Zhang, Shuang Bai, et al.. (2021). Immune Responses to Adjuvanted H7N9 Split Antigen in Aged Mice. Viral Immunology. 34(2). 112–116. 2 indexed citations
18.
Zhao, Wei, Peng Zhang, Shuang Bai, et al.. (2021). Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice. Archives of Virology. 166(12). 3333–3341. 8 indexed citations
19.
Lv, Min, et al.. (2014). Pterostilbene attenuates the inflammatory reaction induced by ischemia/reperfusion in rat heart. Molecular Medicine Reports. 11(1). 724–728. 41 indexed citations
20.
Xie, Zheng, et al.. (2013). [Analysis of the difference in free influenza vaccination rates between old people in urban and rural areas in Beijing].. PubMed. 45(3). 432–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changtai Zhu Breakdown of academic impact, for papers by Denise Pui Chung Chan Breakdown of academic impact, for papers by Erin Burns Breakdown of academic impact, for papers by Eun Hee Chung Breakdown of academic impact, for papers by Florencia Wendkuuni Djigma Breakdown of academic impact, for papers by Hui Zheng Breakdown of academic impact, for papers by Xuewen Tang Breakdown of academic impact, for papers by Benjamin Wyplosz Breakdown of academic impact, for papers by Verónica Saludes Breakdown of academic impact, for papers by Pei Gao
Rankless by CCL
2026